Recently, it was also shown that ASOs targeting Etf1 or Gspt1 (mouse ortholog of human eRF3a/GSPT1) can promote PTC readthrough in a hemophilia mouse model with nonsense mutations, particularly in combination with the readthrough aminoglycoside G418 (20). Here, ETF1 is linked to hemophilia.